FIGURE 7.

RS17 inhibition of tumor growth in vivo. Nude mice were subcutaneously implanted with tumor cells and treated with a subcutaneous injection of RS17 (20 mg/kg), B6H12 (20 mg/kg), or PBS once a day for 28 days. (A) Analysis by in vivo imaging on day 28 (1‐mouse from the RS17 treatment group, 2‐mouse from the B6H12 treatment group, 3‐mouse from the PBS control group). (B) In vivo imaging results were quantified by the average radiant efficiency. (C) The changes tumor volume in mice. (D) Tumor weight in mice on day 28. The results are presented as mean ± SD (n = 5), *p < 0.01, ** p < 0.001